Robert Martell - Jan 20, 2023 Form 4 Insider Report for CURIS INC (CRIS)

Role
Head of Research & Development
Signature
/s/ Diantha Duvall, Attorney-in-fact
Stock symbol
CRIS
Transactions as of
Jan 20, 2023
Transactions value $
$0
Form type
4
Date filed
1/24/2023, 03:09 PM
Previous filing
Jan 31, 2022
Next filing
Feb 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRIS Employee stock option (right to buy) Award $0 +350K $0.00 350K Jan 20, 2023 Common Stock 350K $0.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant described in this Form 4 filing vests as to 25% of the original shares on January 20, 2024 and as to an additional 6.25% of the original shares each successive quarter and until January 20, 2027.

Remarks:

Exhibit Index: 24.1 Power of Attorney